Effect of promipexol versus no treatment in migraine patients with restlessleg syndrome

Phase 2

• Conditions: Migraine.; Migraine

• Registration Number: IRCT201506019014N63
• Lead Sponsor: Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

(a) The frequency of headache at least 4 times a month; (b) headache leads to dysfunction.
Exclusion criteria: (a) breastfeeding and pregnancy; (b) contraindication of promipexol.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessing the frequency of headache. Timepoint: one, two, and three months after treatment . Method of measurement: using questionnaire.

Secondary Outcome Measures

Name	Time	Method
Assessing the dizziness. Timepoint: one, two, and three months after treatment. Method of measurement: using questionnaire.;Assessing the insomnia. Timepoint: one, two, and three months after treatment. Method of measurement: using questionnaire.;Assessing the nausea and vomiting. Timepoint: one, two, and three months after treatment. Method of measurement: using questionnaire.